NCT00015886View on ClinicalTrials.gov

Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 1997

Primary Completion Date

May 31, 2002

Study Completion Date

July 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

docetaxel

75 milligrams per meter squared intraveneously

DRUG

fluorouracil

350 milligrams intraveneously

Trial Locations (6)

27534

Southeastern Medical Oncology Center, Goldsboro

29303

Palmetto Hematology/Oncology Associates, Spartanburg

29605

Cancer Centers of the Carolinas, Greenville

27858-4354

East Carolina University School of Medicine, Greenville

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

23298-0037

Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00015886 - Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery | Biotech Hunter | Biotech Hunter